Clinical trial NCT03328403: Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion
Official title: Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Acute Ischaemic Stroke
Keywords: Endovascular therapy
Mechanical thrombectomy
Acute ischaemic stroke treatment
Lead sponsor: The University of Hong Kong
Sponsor class: OTHER
Collaborators: name: Queen Mary Hospital, Hong Kong
name: Ruttonjee Hospital, Hong Kong
First posted: 2017-11-01
Enrollment: 58
Sex: ALL
Maximum age (years): 80
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Patients will be randomized to use either the Aspiration System or one of the stent-retreivers (Trevo / Solitaire) first. Other devices would be used if the first device failed to open the occluded vessel satisfactorily, depending on clinical situation and the involved interventionists' preferences.
Primary purpose: TREATMENT

Brief summary: Aim of Study:

1. To develop a standardized patient selection criteria and imaging protocol for endovascular therapy in acute ischaemic stroke (AIS)
2. To create a local efficacy and safety database for intra-arterial mechanical thrombectomy devices use
3. To establish predictors for poor functional outcome despite successful recanalization

Study Design:

Prospective

Subject and Site:

100 acute ischaemic stroke patients with large vessel occlusion At Queen Mary and Ruttonjee Hospital, Hong Kong

Duration of participation:

2 years

Entry Criteria:

Subject must meet all inclusion criteria and none of the exclusion criteria

Consent:

Both English and Chinese versions of Informed consent are available and will be obtained from patient or his/her next of kin

Detailed description: Our study aim to set a standard patient selection and imaging protocol based on previous positive trials for endovascular therapy in AIS patients. Local efficacy and safety data of the FDA mechanical devices mainly Penumbra Aspiration System and Solitaire Flow Restoration device will be collected to create a local database for future service development. Clinical predictors for poor clinical outcomes despite successful recanalization will be looked for.

Intra-arterial treatment consisted of arterial catheterization with a micro-catheter and micro-guide wire to the level of occlusion. Mechanical treatment could involve thrombus aspiration technique or use of a retrievable stent. The method of intra-arterial treatment will leave to the discretion of the involved interventionist. Only devices that have received U.S. Food and Drug Administration (FDA) or Conformite Europeenne (CE) approval will be used in the trial. One or more members of each intervention team have to have completed at least five full procedures with a particular type of device.

Outcome and Safety Measures:

The primary outcome is 90 days modified Rankin scale. The modified Rankin scale is a 7-point scale ranging from 0 (no symptoms) to 6 (death). A score of 2 or less indicates functional independence.

Secondary outcomes include:

1. NIHSS score at 24 hours and at 7 day or discharge if earlier
2. Activities of daily living measured using Barthel index and NIHSS at 90 days
3. Percentage of successful recanalization, defined as modified Thrombolysis in Cerebral Infarction (mTICI) of 2b (more that 50% of distal branches visible) or 3 (all distal branches visible) assessed at the end of procedure
4. Efficacy of work flow with time measure on onset to CT, CT to groin puncture, puncture to reperfusion and number of pass of device before successful recanalization
5. Final infarct volume measured by plain CT brain at 3 days after procedure
6. Death

Eligibility criteria: Inclusion Criteria:

* Onset: ≤ 4.5 hours from symptoms onset
* Age \< 80
* Premorbid modified Rankin Score (mRS) ≤ 2
* NIHSS 8 - 29
* Clear and definite symptoms and signs suggesting stroke with hemiparesis as one of the presenting symptoms
* Plain CT brain showed no evidence of intracerebral haemorrhage and ASPECTS ≥ 7
* Multiphasic CT angiogram confirmed proximal vessel occlusion at internal carotid artery (ICA), carotid T junction, proximal middle cerebral artery (M1 segment to proximal M2 with loss of all M2 branches), proximal anterior cerebral artery (segment A1) or basilar artery

Exclusion Criteria:

* Interventionist or angio-laboratory not available
* Neurological signs rapidly resolving
* NIHSS\>29
* Evidence of cerebral haemorrhage or subarachnoid haemorrhage on CT brain
* ASPECTS\<7
* Excessive tortuosity of the vessel precluding device delivery
* Known chronic renal failure with creatinine level \>250umol/L
* Known haemorrhagic diathesis
* Known coagulation factor deficiency
* Difficult blood pressure control with persistent systolic blood pressure \>185mg or diastolic blood pressure \>110mg despite aggressive blood pressure lowering therapy
* On anticoagulant and INR≥3
* On heparin in previous 48 hour and APTT\>2x of normal
* Platelet counts \<30
* Blood glucose \<2.7mmol/L
* Known severe allergies to contrast medium
* Seizure as presenting symptoms with post-ictal hemiparesis
* Life expectancy \< 3months
* Pregnant

Primary outcomes:
measure: Modified Rankin scale
timeFrame: 90 days
Secondary outcomes:
measure: National Institute of Health Stroke Severity Score (NIHSS)
timeFrame: At 24 hours and at 7 day or discharge if earlier
measure: Activities of daily living
timeFrame: 90 days
measure: Percentage of successful recanalization
timeFrame: 1 day
Other outcomes:
Locations:
city: Hong Kong
country: Hong Kong
facility: Queen Mary Hospital
Study officials:
affiliation: Queen Mary Hospital, Hong Kong
name: Mona Man-Yu Tse, MBBS, FHKAM
role: PRINCIPAL_INVESTIGATOR
References: